OKYO OKYO Pharma Limited
Healthcare$1.71+4.91%ClosedMarket Cap: $65.6M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
-17.86
P/S
0.00
EV/EBITDA
-6.10
DCF Value
$-0.11
FCF Yield
-5.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
102.9%
ROA
-99.3%
ROIC
154.2%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q2 null | $0.00 | -Infinity% | $-2.8M | $-2.6M | $— | — |
| Q4 null | $0.00 | -Infinity% | $-4.2M | $-2.0M | $— | — |
| FY null | $0.00 | -Infinity% | $-7.2M | $-4.7M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-3.0M | $-2.7M | $— | — |
| Q4 null | $0.00 | -Infinity% | $-7.0K | $-8.0K | $— | — |
| FY null | $0.00 | -Infinity% | $-15.7M | $-16.8M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-8.7K | $-8.8K | $— | — |
| Q4 null | $0.00 | -Infinity% | $-7.7K | $-7.8K | $— | — |
| FY null | $0.00 | -Infinity% | $-13.1M | $-13.3M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-4.6K | $-4.6K | $— | — |
| Q4 null | $0.00 | -Infinity% | $-6.9M | $-5.8M | $— | — |
| FY null | $0.00 | -Infinity% | $-6.2M | $-5.4M | $— | — |